Plasma Cystatin C and Acute Kidney Injury
Use of Cystatin C in Predicting AKI in Patients Undergone Cardiopulmonary Bypass Surgery
1 other identifier
observational
100
1 country
1
Brief Summary
To evaluate the utility of plasma cystatin C(pCysC) as a predictive and diagnostic marker of acute kidney injury(AKI) in patients undergone cardiopulmonary bypass surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 26, 2012
CompletedFirst Posted
Study publicly available on registry
July 30, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedAugust 6, 2012
August 1, 2012
2.1 years
July 26, 2012
August 3, 2012
Conditions
Keywords
Study Arms (2)
AKI group
patients with AKI after cardiopulmonary bypass surgery
non-AKI group
patients without AKI during study period
Eligibility Criteria
patients undergone cardiopulmonary bypass surgery
You may qualify if:
- patients with CPB and admitted to ICU
You may not qualify if:
- patients with the age \>80 or \<18 years
- with preexisting renal dysfunction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jinhua central hospital
Jinhua, Zhejiang, 321000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Hongying Ni, MM
Jinhua Municipal Central Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department vice director
Study Record Dates
First Submitted
July 26, 2012
First Posted
July 30, 2012
Study Start
April 1, 2011
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
August 6, 2012
Record last verified: 2012-08